Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Anne‐Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3895-3895
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Alzheimer's disease: From immunotherapy to immunoprevention
Mathias Jucker, Lary C. Walker
Cell (2023) Vol. 186, Iss. 20, pp. 4260-4270
Open Access | Times Cited: 110
Classification of Alzheimer’s disease using MRI data based on Deep Learning Techniques
Shaymaa E. Sorour, Amr A. Abd El-Mageed, Khalied M. Albarrak, et al.
Journal of King Saud University - Computer and Information Sciences (2024) Vol. 36, Iss. 2, pp. 101940-101940
Open Access | Times Cited: 36
Passive immunotherapy for Alzheimer's disease
Xiaoyi Guo, Yan Li, Denghong Zhang, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102192-102192
Open Access | Times Cited: 23
Alzheimer’s Disease: The Past, Present, and Future of a Globally Progressive Disease
Bhuvanasai Vejandla, Sarah Savani, Rohith Appalaneni, et al.
Cureus (2024)
Open Access | Times Cited: 16
A Survey of Deep Learning for Alzheimer’s Disease
Qinghua Zhou, Jiaji Wang, Xiang Yu, et al.
Machine Learning and Knowledge Extraction (2023) Vol. 5, Iss. 2, pp. 611-668
Open Access | Times Cited: 22
Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 8
Progress and trends in neurological disorders research based on deep learning
Muhammad Shahid Iqbal, Md Belal Bin Heyat, Saba Parveen, et al.
Computerized Medical Imaging and Graphics (2024) Vol. 116, pp. 102400-102400
Closed Access | Times Cited: 8
Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
Iram Iqbal, Fatima Saqib, Zobia Mubarak, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 7
The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
Tao Wang, Hongmei Jia
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12025-12025
Open Access | Times Cited: 15
[125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease
Christopher Liang, Cayz G. Paclibar, Noresa L. Gonzaga, et al.
Neurology International (2024) Vol. 16, Iss. 2, pp. 419-431
Open Access | Times Cited: 5
The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications
William A. Banks, Elizabeth M. Rhea, May J. Reed, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101760-101760
Open Access | Times Cited: 5
Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Radhakrishna Reddi Sree, Manjunath Kalyan, Nikhilesh Anand, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5148-5171
Open Access
Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer’s disease
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108241-108241
Closed Access
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Sahar Balkhi, Antimo Di Spirito, Alessandro Poggi, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 264-264
Open Access
Neuron-Astrocyte Interactions in Aging and Alzheimer's Disease: Dysregulation of Amyloid Precursor Protein
Gretsen Velezmoro Jáuregui, Vladimir Parpura
Ageing & Longevity (2025), Iss. 2. 2025, pp. 117-128
Closed Access
Monoclonal Antibody Therapy in Alzheimer’s Disease
Monica Neațu, Anca Covaliu, Iulia Ioniță, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 60-60
Open Access | Times Cited: 12
Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models
Andreea-Daniela Meca, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarțău, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5929-5949
Open Access | Times Cited: 3
Best Medicine for Dementia: The Life-Long Defense of the Brain
Marcus J. Andersson, Jonathan Stone
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. 1, pp. 51-66
Closed Access | Times Cited: 9
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Zhaodi Xia, Ruo‐xin Ma, Jinfeng Wen, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. 4, pp. 1265-1301
Closed Access | Times Cited: 8
Managing ferroptosis-related diseases with indirect dietary modulators of ferroptosis
Lixing Cao, Shuang Zhao, Kai Han, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 120, pp. 109427-109427
Open Access | Times Cited: 8
Causal relationship between dementia and delirium: Insights from a bidirectional two-sample Mendelian randomization analysis
Yongsong Cai, Jiachen Wang, Xinyi Wang, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 69-76
Closed Access | Times Cited: 2
Insights into Dysregulated Neurological Biomarkers in Cancer
Elisa Duranti, Chiara Villa
Cancers (2024) Vol. 16, Iss. 15, pp. 2680-2680
Open Access | Times Cited: 2
A glance through the effects of CD4+ T cells, CD8+ T cells, and cytokines on Alzheimer's disease
Atefeh Afsar, Min Chen, Zhenyu Xuan, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5662-5675
Open Access | Times Cited: 5
Exploration of Alzheimer's disease-related gene expression following high-intensity and moderate-intensity exercise interventions
Kieran J. Marston, Jaisalmer de Frutos‐Lucas, Tenielle Porter, et al.
Journal of science and medicine in sport (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top